The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: Betting on Horse Races & the Baseball MVP Machine

Ep. 153

Show from 6/5/19


Cade Massey and Shane Jensen fly solo at the top of the show and manage to sneak in some football, Canadian football to be exact! Then the NBA Finals are locked at one game apiece after the Warriors took game two. Tune in for an analytical look at what is now a pivotal game three and the potential impact of welcoming Kevin Durant back into the fold.  Plus two guest segments on horse betting and MLB's switch to data driven baseball. What are the effects of the 'MVP Machine?' Find out in this episode of Wharton Moneyball.


Guests:

Etan Green - Assistant Professor of Operations, Information and Decisions at the Wharton School at the University of Pennsylvania. His research focuses on judgment and decision making among experts, including professional athletes and referees in sports.

Follow his research here: https://oid.wharton.upenn.edu/profile/etangr/


Ben Lindbergh – Co-Author of The MVP Machine: How Baseball's New Nonconformists Are Using Data to Build Better Players with Travis Sawchik. Fifteen years after Michael Lewis brought the Oakland Athletics' groundbreaking team-building strategies to light, every front office takes a data-driven approach to evaluating players, and the league's smarter teams no longer have a huge advantage in valuing past performance.The book charts the future of a sport and offers a lesson that goes beyond baseball: Success stems not from focusing on finished products, but from making the most of untapped potential.

Check out the book here: https://www.amazon.com/MVP-Machine-Baseballs-Nonconformists-Players/dp/1541698940

Follow him on Twitter: @BenLindbergh

More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.